MedPath

Pathway Therapeutics, Inc.

Pathway Therapeutics, Inc. logo
🇺🇸United States
Ownership
Private
Established
2008-01-01
Employees
11
Market Cap
-
Website
http://pathwaytx.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Study of PWT33597 Mesylate in Subjects With Advanced Malignancies

Phase 1
Completed
Conditions
Malignancies
First Posted Date
2011-08-02
Last Posted Date
2012-10-25
Lead Sponsor
Pathway Therapeutics, Inc.
Target Recruit Count
22
Registration Number
NCT01407380
Locations
🇺🇸

Pinnacle Hematology Oncology, Scottsdale, Arizona, United States

🇺🇸

The University of Arizona Cancer Center, Tucson, Arizona, United States

🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.